Patent Assignment
Reel/Frame 040588/0101
Assignment of Assignor's Interest
Recorded: 2016-12-07
Pages: 5
Assignor
ESPELIN, CHRISTOPHER W.
Executed: 2016-06-23
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(2)
Combination Therapies for Treating HER2-Positive Cancers That Are Resistant to HER2-Targeted Therapies
Combination Therapies for Treating HER2-Positive Cancers That Are Resistant to HER2-Targeted Therapies
Application:
62/033,423 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 1, 2015
From: GERETTI, ELENA; MOYO, VICTOR; REYNOLDS, JOSEPH G.; WICKHAM, THOMAS
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 036706/0912 →
Assignment of Assignor's Interest
Oct 1, 2015
From: GERETTI, ELENA; MOYO, VICTOR; REYNOLDS, JOSEPH G.; WICKHAM, THOMAS
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 036707/0054 →
Security Interest
Dec 28, 2015
From: MERRIMACK PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 037394/0285 →
Assignment of Assignor's Interest
Nov 9, 2016
From: HENDRIKS, BART S.
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 040261/0941 →
Release of Security Interest
Apr 14, 2017
From: U.S. BANK NATIONAL ASSOCIATION
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 042254/0349 →